{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:13:18Z","timestamp":1791972798515,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM008562-23"],"award-info":[{"award-number":["GM008562-23"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011086","name":"NASPGHAN Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020218","name":"Chiesi USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10620-024-08728-8","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T22:59:09Z","timestamp":1731538749000},"page":"968-977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proton-Pump Inhibitors and Fat Absorption in Cystic Fibrosis and Pancreatic Insufficiency: A Randomized Crossover Pilot Trial"],"prefix":"10.1007","volume":"70","author":[{"given":"Anna Evans","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson N.","family":"Brownell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Tindall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget Dowd","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiren","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia A.","family":"Stallings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"8728_CR1","doi-asserted-by":"publisher","first-page":"CD003424","DOI":"10.1002\/14651858.CD003424.pub5","volume":"4","author":"SM Ng","year":"2021","unstructured":"Ng SM, Moore HS. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Cochrane Database Syst Rev 2021;4:CD003424. https:\/\/doi.org\/10.1002\/14651858.CD003424.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"8728_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/01.mpg.0000252190.97545.07","volume":"44","author":"TI Omari","year":"2007","unstructured":"Omari TI, Haslam RR, Lundborg P et al. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007;44:41\u201344. https:\/\/doi.org\/10.1097\/01.mpg.0000252190.97545.07.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"8728_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MPG.0000000000003063","volume":"72","author":"R Orel","year":"2021","unstructured":"Orel R, Benninga MA, Broekaert IJ et al. Drugs in focus: proton-pump inhibitors. J Pediatr Gastroenterol Nutr 2021;72:645\u2013653. https:\/\/doi.org\/10.1097\/MPG.0000000000003063.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"8728_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/bega.2001.0195","volume":"15","author":"EP DiMagno","year":"2001","unstructured":"DiMagno EP. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. Best Pract Res Clin Gastroenterol 2001;15:477\u2013486. https:\/\/doi.org\/10.1053\/bega.2001.0195.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"8728_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/s0022-3476(95)70153-2","volume":"127","author":"DS Borowitz","year":"1995","unstructured":"Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 1995;127:681\u2013684. https:\/\/doi.org\/10.1016\/s0022-3476(95)70153-2.","journal-title":"J Pediatr"},{"key":"8728_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/BF02087549","volume":"39","author":"MJ Bruno","year":"1994","unstructured":"Bruno MJ, Rauws EA, Hoek FJ et al. Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy. Dig Dis Sci 1994;39:988\u2013992. https:\/\/doi.org\/10.1007\/BF02087549.","journal-title":"Dig Dis Sci"},{"key":"8728_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/BF01536271","volume":"34","author":"F Marotta","year":"1989","unstructured":"Marotta F, O\u2019Keefe SJ, Marks IN et al. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating. Dig Dis Sci 1989;34:456\u2013461. https:\/\/doi.org\/10.1007\/BF01536271.","journal-title":"Dig Dis Sci"},{"key":"8728_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","volume":"66","author":"R Rosen","year":"2018","unstructured":"Rosen R, Vandenplas Y, Singendonk M et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition and the European society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr 2018;66:516\u2013554. https:\/\/doi.org\/10.1097\/MPG.0000000000001889.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"8728_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamapediatrics.2020.5710","volume":"175","author":"Y-H Wang","year":"2021","unstructured":"Wang Y-H, Wintzell V, Ludvigsson JF et al. Association between proton-pump inhibitor use and risk of asthma in children. JAMA Pediatr 2021;175:394\u2013403. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.5710.","journal-title":"JAMA Pediatr"},{"key":"8728_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamapediatrics.2020.0007","volume":"174","author":"Y-H Wang","year":"2020","unstructured":"Wang Y-H, Wintzell V, Ludvigsson JF et al. Association between proton-pump inhibitor use and risk of fracture in children. JAMA Pediatr 2020;174:543\u2013551. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.0007.","journal-title":"JAMA Pediatr"},{"key":"8728_CR11","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00198-015-3168-0","volume":"26","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Haynes K, Denburg MR et al. Use of proton-pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporos Int 2015;26:2501\u20132507. https:\/\/doi.org\/10.1007\/s00198-015-3168-0.","journal-title":"Osteoporos Int"},{"key":"8728_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/apt.14796","volume":"48","author":"KT Tran","year":"2018","unstructured":"Tran KT, McMenamin \u00daC, Hicks B et al. Proton-pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies. Aliment Pharmacol Ther 2018;48:55\u201364. https:\/\/doi.org\/10.1111\/apt.14796.","journal-title":"Aliment Pharmacol Ther"},{"key":"8728_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s40272-023-00580-z","volume":"25","author":"J Tan","year":"2023","unstructured":"Tan J, Jeffries S, Carr R. A review of histamine-2 receptor antagonist and proton-pump inhibitor therapy for gastroesophageal reflux disease in neonates and infants. Paediatr Drugs 2023;25:557\u2013576. https:\/\/doi.org\/10.1007\/s40272-023-00580-z.","journal-title":"Paediatr Drugs"},{"key":"8728_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton-pump inhibitors: expert review and best practice advice from the American gastroenterological association. Gastroenterology 2017;152:706\u2013715. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.031.","journal-title":"Gastroenterology"},{"key":"8728_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/MPA.0000000000001587","volume":"49","author":"H Bashaw","year":"2020","unstructured":"Bashaw H, Brownell JN, Schall JI et al. Measures of dietary fat and energy absorption in healthy adults. Pancreas 2020;49:845\u2013854. https:\/\/doi.org\/10.1097\/MPA.0000000000001587.","journal-title":"Pancreas"},{"key":"8728_CR16","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1097\/MPA.0000000000001381","volume":"48","author":"JN Brownell","year":"2019","unstructured":"Brownell JN, Schall JI, Stallings VA. Pancreatic function in chronic pancreatitis: a cohort study comparing 3 methods of detecting fat malabsorption and the impact of short-term pancreatic enzyme replacement therapy. Pancreas 2019;48:1068\u20131078. https:\/\/doi.org\/10.1097\/MPA.0000000000001381.","journal-title":"Pancreas"},{"key":"8728_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/jcph.484","volume":"55","author":"MR Mascarenhas","year":"2015","unstructured":"Mascarenhas MR, Mondick J, Barrett JS et al. Malabsorption blood test: assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency. J Clin Pharmacol 2015;55:854\u2013865. https:\/\/doi.org\/10.1002\/jcph.484.","journal-title":"J Clin Pharmacol"},{"key":"8728_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5414\/CP201793","volume":"51","author":"VA Stallings","year":"2013","unstructured":"Stallings VA, Mondick JT, Schall JI et al. Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis. Int J Clin Pharmacol Ther 2013;51:263\u2013273. https:\/\/doi.org\/10.5414\/CP201793.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"8728_CR19","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","volume":"58","author":"D Gelfond","year":"2013","unstructured":"Gelfond D, Ma C, Semler J et al. Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule. Dig Dis Sci 2013;58:2275\u20132281. https:\/\/doi.org\/10.1007\/s10620-012-2209-1.","journal-title":"Dig Dis Sci"},{"key":"8728_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jpepsy\/jsg044","volume":"28","author":"AC Modi","year":"2003","unstructured":"Modi AC, Quittner AL. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003;28:535\u2013545. https:\/\/doi.org\/10.1093\/jpepsy\/jsg044.","journal-title":"J Pediatr Psychol"},{"key":"8728_CR21","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","volume":"128","author":"AL Quittner","year":"2005","unstructured":"Quittner AL, Buu A, Messer MA et al. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005;128:2347\u20132354. https:\/\/doi.org\/10.1378\/chest.128.4.2347.","journal-title":"Chest"},{"key":"8728_CR22","first-page":"S53","volume":"23","author":"JF Fries","year":"2005","unstructured":"Fries JF, Bruce B, Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 2005;23:S53\u2013S57.","journal-title":"Clin Exp Rheumatol"},{"key":"8728_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","volume":"19","author":"JM Shin","year":"2013","unstructured":"Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton-pump inhibitors. J Neurogastroenterol Motil 2013;19:25\u201335. https:\/\/doi.org\/10.5056\/jnm.2013.19.1.25.","journal-title":"J Neurogastroenterol Motil"},{"key":"8728_CR24","unstructured":"Anon. Prilosec (omeprazole) [Package Insert] U.S. Food and Drug Administration Web site. 2012"},{"key":"8728_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/s0022-3476(05)81561-6","volume":"123","author":"TS Gunasekaran","year":"1993","unstructured":"Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993;123:148\u2013154. https:\/\/doi.org\/10.1016\/s0022-3476(05)81561-6.","journal-title":"J Pediatr"},{"key":"8728_CR26","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/jamapediatrics.2023.2906","volume":"177","author":"JG Berry","year":"2023","unstructured":"Berry JG, Mansbach JM. Questionable safety of proton-pump inhibitor use in children. JAMA Pediatr 2023;177:1010\u20131012. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.2906.","journal-title":"JAMA Pediatr"},{"key":"8728_CR27","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamapediatrics.2023.2900","volume":"177","author":"M Lassalle","year":"2023","unstructured":"Lassalle M, Zureik M, Dray-Spira R. Proton-pump inhibitor use and risk of serious infections in young children. JAMA Pediatr 2023;177:1028\u20131038. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.2900.","journal-title":"JAMA Pediatr"},{"key":"8728_CR28","doi-asserted-by":"publisher","first-page":"e20182625","DOI":"10.1542\/peds.2018-2625","volume":"144","author":"L Malchodi","year":"2019","unstructured":"Malchodi L, Wagner K, Susi A et al. Early acid suppression therapy exposure and fracture in young children. Pediatrics 2019;144:e20182625. https:\/\/doi.org\/10.1542\/peds.2018-2625.","journal-title":"Pediatrics"},{"key":"8728_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/phar.2125","volume":"38","author":"BE McCrory","year":"2018","unstructured":"McCrory BE, Harper HN, McPhail GL. Use and incidence of adverse effects of proton-pump inhibitors in patients with cystic fibrosis. Pharmacotherapy 2018;38:725\u2013729. https:\/\/doi.org\/10.1002\/phar.2125.","journal-title":"Pharmacotherapy"},{"key":"8728_CR30","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1111\/apa.16491","volume":"111","author":"M Lyamouri","year":"2022","unstructured":"Lyamouri M, M\u00e5rild K, Nielsen RG et al. Proton-pump inhibitors for infants in three Scandinavian countries increased from 2007 to 2020 despite international recommendations. Acta Paediatr 2022;111:2222\u20132228. https:\/\/doi.org\/10.1111\/apa.16491.","journal-title":"Acta Paediatr"},{"key":"8728_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/MPA.0b013e31828784ef","volume":"42","author":"S Sander-Struckmeier","year":"2013","unstructured":"Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G et al. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase\/pancreatin (CREON\u00ae) in patients with pancreatic exocrine insufficiency. Pancreas 2013;42:983\u2013989. https:\/\/doi.org\/10.1097\/MPA.0b013e31828784ef.","journal-title":"Pancreas"},{"key":"8728_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","volume":"93","author":"AK Nehra","year":"2018","unstructured":"Nehra AK, Alexander JA, Loftus CG et al. Proton-pump inhibitors: review of emerging concerns. Mayo Clin Proc 2018;93:240\u2013246. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.022.","journal-title":"Mayo Clin Proc"},{"key":"8728_CR33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1592\/phco.27.6.910","volume":"27","author":"M Ferrone","year":"2007","unstructured":"Ferrone M, Raimondo M, Scolapio JS. Pancreatic enzyme pharmacotherapy. Pharmacotherapy 2007;27:910\u2013920. https:\/\/doi.org\/10.1592\/phco.27.6.910.","journal-title":"Pharmacotherapy"},{"key":"8728_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/j.1552-4604.1994.tb03981.x","volume":"34","author":"M Kraisinger","year":"1994","unstructured":"Kraisinger M, Hochhaus G, Stecenko A et al. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 1994;34:158\u2013166. https:\/\/doi.org\/10.1002\/j.1552-4604.1994.tb03981.x.","journal-title":"J Clin Pharmacol"},{"key":"8728_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ajg.2017.263","volume":"113","author":"R Yadlapati","year":"2018","unstructured":"Yadlapati R, Tye M, Keefer L et al. Psychosocial distress and quality of life impairment are associated with symptom severity in PPI non-responders with normal impedance-pH profiles. Am J Gastroenterol 2018;113:31\u201338. https:\/\/doi.org\/10.1038\/ajg.2017.263.","journal-title":"Am J Gastroenterol"},{"key":"8728_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cgh.2012.01.022","volume":"10","author":"PJ Kahrilas","year":"2012","unstructured":"Kahrilas PJ, Jonsson A, Denison H et al. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012;10:612\u2013619. https:\/\/doi.org\/10.1016\/j.cgh.2012.01.022.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8728_CR37","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.1542\/peds.2005-1655","volume":"117","author":"RB Canani","year":"2006","unstructured":"Canani RB, Cirillo P, Roggero P et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817\u2013e820. https:\/\/doi.org\/10.1542\/peds.2005-1655.","journal-title":"Pediatrics"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08728-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:22:24Z","timestamp":1742314944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08728-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["8728"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08728-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors disclose they have no conflicts of interest related to this project and manuscript. The funding sources had no role in study design, analysis, or drafting of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}